Organigram Global (OGI) Capital Expenditures (2018 - 2026)
Organigram Global (OGI) posted quarterly Capital Expenditures of -$1.7 million for Q1 2026, up 62.59% year-over-year from -$1.0 million in Q1 2025, and down 12.47% quarter-over-quarter from -$1.5 million in Q4 2025.
Organigram Global (OGI) Capital Expenditures (2018 - 2026) Analysis & Trends
Organigram Global (OGI) has reported Capital Expenditures for 7 consecutive years, with -$1.7 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Capital Expenditures rose 62.59% year-over-year to -$1.7 million; the TTM figure through Mar 2026 stood at -$8.9 million (down 5.35% YoY), while the FY2025 annual figure was $12.4 million, up 256.65% from the prior year.
- Capital Expenditures declined to -$1.7 million in Q1 2026 per OGI's latest filing, from -$1.5 million in the prior quarter.
- Across five years, Capital Expenditures topped out at -$1.2 million in Q4 2024 and bottomed at -$4.5 million in Q1 2025.
- Historically, Capital Expenditures has averaged -$2.2 million across 3 years, with a median of -$1.6 million in 2025.
- Annual changes were most pronounced in 2025 — Capital Expenditures slipped 29.62% — and 2026, when it jumped 62.59%.
- Organigram Global's Capital Expenditures stood at -$1.2 million in 2024, then slipped by 29.62% to -$1.5 million in 2025, then retreated by 12.47% to -$1.7 million in 2026.
- Business Quant data shows OGI's Capital Expenditures at -$1.7 million in Q1 2026, -$1.5 million in Q4 2025, and -$4.5 million in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.42 Bn | 39.76 Bn | 2.15 Bn | 104.00 Mn |
| 3 | Zoetis | 31.86 Bn | 30.18 Bn | 1.05 Bn | 117.00 Mn |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.98 Bn | 5.10 Bn | -337.60 Mn |
| 5 | United Therapeutics | 22.29 Bn | 19.63 Bn | 683.80 Mn | 108.00 Mn |
| 6 | Viatris | 18.78 Bn | 17.89 Bn | 1.46 Bn | 52.80 Mn |
| 7 | Neurocrine Biosciences | 15.66 Bn | 15.27 Bn | 935.80 Mn | 7.80 Mn |
| 8 | Elanco Animal Health | 11.91 Bn | 11.38 Bn | 798.00 Mn | 33.00 Mn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - | - |
| 10 | Organigram Global | 150.66 Mn | 150.54 Mn | 28.97 Mn | -1.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.70 Mn |
| Mar 31, 2026 | -1.70 Mn |
| Dec 31, 2025 | -1.51 Mn |
| Dec 31, 2025 | -1.51 Mn |
| Mar 31, 2025 | -4.54 Mn |
| Mar 31, 2025 | -4.54 Mn |
| Dec 31, 2024 | -1.16 Mn |
| Dec 31, 2024 | -1.16 Mn |
| May 31, 2021 | -6.38 Mn |
| May 31, 2021 | -6.38 Mn |
| Feb 28, 2021 | 3.63 Mn |
| Feb 28, 2021 | 3.63 Mn |
| Nov 30, 2020 | -1.81 Mn |
| Nov 30, 2020 | -1.81 Mn |
| Aug 31, 2020 | -9.23 Mn |
| Aug 31, 2020 | -9.23 Mn |
| May 31, 2020 | -17.63 Mn |
| May 31, 2020 | -17.63 Mn |
| Feb 29, 2020 | 64,973.00 |
| Feb 29, 2020 | 64,973.00 |